November 27, 2022
Loading...
You are here:  Home  >  'Amgen'
Latest

Amgen income tops $2B in Q3

By   /  Thursday, November 3rd, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, middle, Regions, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Amgen income tops $2B in Q3

Thousand Oaks-based Amgen saw a slight decline in revenue for the third quarter of 2022, but a substantial increase in earnings helped the company beat analysts’ expectations and maintain its stock price. One of the largest biotechnology companies in the world, Amgen delivered net income of $2.1 billion, or $3.98 per share, in the third Read More →

Latest

Amgen shares up amid optimism over experimental weight-loss drug

By   /  Thursday, October 13th, 2022  /  Banking & Finance, Health Care & Life Science, Latest news, left, Regions, Subscriber content, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Amgen shares up amid optimism over experimental weight-loss drug

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

At CLU forum, employers are resigned to the new jobs reality

By   /  Friday, September 30th, 2022  /  Latest news, middle, Regions, Subscriber content, Top Stories, Ventura County  /  Comments Off on At CLU forum, employers are resigned to the new jobs reality

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Amgen sees blockbuster potential in new cancer drug

By   /  Friday, September 16th, 2022  /  Health Care & Life Science, Latest news, Regions, Subscriber content, Top Stories, Ventura County  /  Comments Off on Amgen sees blockbuster potential in new cancer drug

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Sonos leads the way in patents among region’s companies

By   /  Friday, September 2nd, 2022  /  Latest news, Regions, San Luis Obispo County, Santa Barbara County, Subscriber content, Technology, Top Stories, Ventura County  /  Comments Off on Sonos leads the way in patents among region’s companies

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Amgen reports pair of positive clinical trial results

By   /  Thursday, September 1st, 2022  /  Banking & Finance, Health Care & Life Science, Latest news, Regions, Tri-County Public Companies, Ventura County  /  Comments Off on Amgen reports pair of positive clinical trial results

Amgen announced positive results from clinical trials of two separate drugs in late August. On Aug. 30, the Thousand Oaks-based biotech giant said its Phase 3 trail evaluating daily oral doses of Lumakras, a treatment for non-small cell lung cancer, “met its primary endpoint of progression-free survival” and demonstrated statistically significant superiority over the current Read More →

Latest

Amgen beats analysts’ expectations for earnings and revenue in Q2

By   /  Thursday, August 4th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Subscriber content, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Amgen beats analysts’ expectations for earnings and revenue in Q2

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.